Cribstone Capital Management, LLC Arch Therapeutics, Inc. Transaction History

Cribstone Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 08, 2020	SELL	$0.13 - $0.29 $3,287 - $7,333	-25,288 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$0.26 - $0.66 $1,300 - $3,300	5,000 Added 24.65%	25,288 $12,000
Q3 2017 Oct 30, 2017	BUY	$0.8 - $0.81 $16,230 - $16,433	20,288	20,288 $16,000

Ticker ARTH
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,886,000
Market Cap $240M
Description
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flag...

Get notified when there are updates to the investment portfolio of Cribstone Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cribstone Capital Management, LLC with notifications on news.